Amitech Therapeutic Solutions, Inc.

Calculating rank

USPTO Granted Patents = 4

% Expired Patents = 50.0

Forward Citations = 6

Loading Chart...

3 inventors (with patents filed for the assignee):

Eric A Murphy (4 out of 15 patents)

Lee Daniel Arnold (4 out of 40 patents)

David A Cheresh (1 out of 28 patents)

4 patents: Sort by Forward Citations

1. 10214513 - Heterocyclic compounds useful for kinase inhibition (2019-02-26),

2. 9260417 - Therapeutic methods and compositions involving allosteric kinase inhibition (2016-02-16),

3. 9212151 - Heterocyclic compounds useful for kinase inhibition (2015-12-15),

4. 8957216 - Heterocyclic compounds useful for kinase inhibition (2015-02-17),

Company Overview

Amitech Therapeutic Solutions, Inc. is a biotechnology company focused on developing innovative therapeutics for the treatment of cancer. The company's proprietary drug delivery technology aims to improve efficacy and reduce side effects of cancer treatments. With a team of experienced scientists and researchers, Amitech is dedicated to advancing the field of oncology and improving patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

4 Patents

#76 in La Jolla, CA

#14,063 in California

#60,626 in US

La Jolla, CA, United States of America